why choose us

300×250 Ad Slot

Research Article: Engineered IRES-mediated promoter-free insulin-producing cells reverse hyperglycemia

Date Published: 2024-08-30

Abstract:
Background: Endogenous insulin supplementation is essential for individuals with type 1 diabetes (T1D). However, current treatments, including pancreas transplantation, insulin injections, and oral medications, have significant limitations. The development of engineered cells that can secrete endogenous insulin offers a promising new therapeutic strategy for type 1 diabetes (T1D). This approach could potentially circumvent autoimmune responses associated with the transplantation of differentiated ?-cells or systemic delivery of viral vectors.

No summary available.

300×250 Ad Slot